Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 23, 2011. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,000,000 Ordinary shares of 25 pence each.
- Purchase Date: November 23, 2011.
- Price Range: Highest price paid was 1,366 pence per share; lowest price paid was 1,346.5 pence per share.
- Treasury Holdings (Settled): 522,462,927 shares (9.37% of total issued share capital).
- Treasury Holdings (Including Unsettled): 526,162,927 shares (10.42% of current total voting rights).
- Shares in Issue (Excluding Treasury): 5,050,586,602 shares.
Material Changes
The primary material change is the reduction of outstanding shares through the purchase of 1,000,000 shares, increasing the proportion of shares held in Treasury. The filing does not disclose changes in operating performance or financial position compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase or subscribe for securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (522,462,927 settled) against the company's latest capitalization table.
- Confirm the percentage of total voting rights represented by treasury shares (10.42% including unsettled purchases).
- Check the remaining authorized share buyback limit under the authority granted on May 5, 2011.
- Review the settlement status of the 3,700,000 shares included in the "including shares which have been purchased but not yet settled" figure.